ST. JUDE MEDICAL ANNOUNCES FDA CLEARANCE OF ENSITE SYSTEM 6 SOFTWARE FOR CARDIAC MAPPING AND NAVIGATION

St. Jude Medical, Inc. announced May 15 U.S. Food and Drug Administration (FDA) clearance of the EnSite System Version 6 software, which provides improved clinical capabilities for cardiac mapping and navigation during electrophysiology (EP) procedures.
St. Jude Medical